Drug Profile
Research programme: dengue fever therapies - Novartis Institute for Tropical Diseases
Alternative Names: Antivirals - Novartis Institute for Tropical Diseases; Dengue therapies - Novartis Institute for Tropical DiseasesLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Novartis Institute for Tropical Diseases
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Dengue
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Dengue in Singapore